Related Experiment Video
Updated: May 10, 2026

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
Published on: February 19, 2016
Recent patents on nonlamellar liquid crystalline lipid phases in drug delivery
Rumiana Koynova1, Boris Tenchov
1Ohio State University College of Pharmacy, 517 Parks Hall, 500 W 12th Ave, Columbus, OH 43210, USA. rkoynova@gmail.com.
Abstract:
Lipid aggregates, mainly liposomes, have been used as drug carriers for quite some time. Recently, nonlamellar liquid crystalline lipid systems, such as inverted bicontinuous cubic, hexagonal and sponge mesophases, attract attention as possible drug-delivery vehicles because of their unique microstructure and physicochemical properties. Various bioactive molecules can be solubilized and protected from hydrolysis or oxidation in either the aqueous or the oil lipid phase. Nonlamellar liquid crystalline lipid aggregates have demonstrated high encapsulating capacity and ability for controlled release of drugs. Valuable properties such as a wide solubilization spectrum, high drug payloads, effective encapsulation, stabilization and protection of sensitive drug substances, define the nonlamellar lipid aggregates as promising pharmaceutical carriers. This review summarizes the recent patents on new formulations based on nonlamellar liquid crystalline lipid phases and their efficiency as drug carriers.
More Related Videos
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Bioavailability Enhancement: Drug Permeability Enhancement
Oral Drug Delivery Systems: Delayed-Release Systems
Modified-Release Drug Delivery Systems: Classification
Modified-Release Drug Delivery Systems: Rate-Programmed II
Site-Targeted Drug Delivery Systems: Polymeric Carriers

